RELATED CONTENT
High-risk prostate cancer patients who receive radiation therapy and an 18-month course of androgen deprivation therapy recover a normal testosterone level in a shorter amount of time compared to those who receive a 36-month course of ADT, thus resulting in a better quality of life and without detriment to long-term outcomes, according to research presented at ASTRO 2014.
September 15, 2014 
Patient-reported data indicates that when Manuka honey is prescribed for esophagitis pain during radiation therapy (RT), it is not more effective than standard medical care, according to research presented at the American Society for Radiation Oncology’s (ASTRO’s) 56th Annual Meeting.
September 15, 2014 
Patients with stage I and II Hodgkin’s Disease who receive consolidated radiation therapy (RT) have a higher 10-year survival rate of 84 percent, compared to 76 percent for patients who did not receive RT; and, the data also shows a decrease in utilization of RT, according to research presented today at the American Society for Radiation Oncology’s (ASTRO’s) 56th Annual Meeting.
September 15, 2014 September 11, 2014 — Radiation therapy with concurrent paclitaxel chemotherapy following surgery is an effective treatment for patients with high-risk endometrial cancer, according to a study published in the Sept. 1, 2014 edition of the International Journal of Radiation Oncology ? Biology ? Physics (Red Journal), the official scientific journal of the American Society for Radiation Oncology (ASTRO).
September 11, 2014 
August 27, 2014 — The American Society for Radiation Oncology (ASTRO) has selected San Francisco Bay Area resident and cancer survivor Jasan Zimmerman to receive the 2014 Survivor Circle Award. Mr. Zimmerman will be presented with his award, including $1,000, during the awards ceremony on Tuesday, Sept. 16, at ASTRO’s 56th annual meeting at San Francisco’s Moscone Center.
August 27, 2014 August 6, 2014 — Standardizing prescribing practices for single-fraction radiation therapy (SFRT) for palliation of bone metastases could lead to cost savings and improvement in patients' quality of life, according to a study published in the Aug. 1 edition of the International Journal of Radiation Oncology • Biology • Physics (Red Journal), the official scientific journal of the American Society for Radiation Oncology (ASTRO).
August 06, 2014 August 4, 2014 — A two-step decision tree analysis, incorporating Donabedian’s model, is a feasible process to evaluate and distill the many available quality standards, guidelines, recommendations and indicators in order to update national and international quality standards for radiation therapy, according to a study published in the July/August 2014 issue of Practical Radiation Oncology (PRO).
August 04, 2014 
July 11, 2014 — The American Society for Radiation Oncology (ASTRO) and the American Association of Physicists in Medicine (AAPM) announced the launch of RO-ILS, or Radiation Oncology Incident Learning System, a new, national patient safety initiative to facilitate safer and higher quality radiation oncology care.
July 11, 2014 The American Society for Radiation Oncology (ASTRO) has issued a new model policy for proton beam therapy (PBT) that details which cancer diagnoses meet ASTRO’s evidence-based standards and should be covered by private insurers and Medicare.
June 05, 2014 
The American Society for Radiation Oncology (ASTRO) is concerned by the Medicare Evidence Development and Coverage Advisory Committee’s (MEDCAC) April 30, 2014 recommendation to the Centers for Medicare and Medicaid Services (CMS) that adults at high risk for lung cancer should not receive Medicare coverage of annual, low-dose computed tomography (LDCT) screening.
May 06, 2014